Medicine and Dentistry
Colorectal Carcinoma
100%
Clinician
75%
Prospective Cohort Study
66%
Systematic Review
50%
Medical Student
50%
Survival Prediction
50%
Bleeding
50%
Orthopedic Trauma
50%
Diabetic Ketoacidosis
50%
Injury
50%
Emergency Care
50%
Sodium Glucose Cotransporter 2 Inhibitor
50%
Observational Study
50%
Medicine
37%
Randomized Controlled Trial
33%
Lymph Node
18%
Neoplasm
18%
Critical Appraisal
16%
Multiple Organ Dysfunction Syndrome
16%
Supplementation
16%
Sepsis
16%
Erythrocyte
16%
Thromboembolism
16%
Checklist
16%
Malignant Neoplasm
12%
Intensive Care Unit
12%
Surgery
12%
Femur Fracture
12%
Surgical Emergency
12%
Adverse Event
12%
Blood Glucose
12%
Hip Replacement
12%
Maturity Onset Diabetes of the Young
12%
Neck
12%
Flexibility
10%
Preoperative Treatment
8%
Rectum Carcinoma
8%
All Cause Mortality
6%
Proportional Hazards Model
6%
Cancer Staging
6%
Overall Survival
6%
Neoadjuvant Therapy
6%
Cohort Analysis
6%
Mortality Rate
6%
Keyphrases
Prospective Cohort Study
50%
Ergonomic Effects
50%
Orthopaedic Trauma Patients
50%
Euglycemic Diabetic Ketoacidosis
50%
Major Haemorrhage
50%
Pathology Report
50%
Colorectal Cancer
50%
Transfusion Strategy
50%
Virtual Age
50%
Survival Prediction
50%
Major Haemorrhage Protocol
25%
Preoperative Therapy
20%
Tumor Location
16%
Pathological Characteristics
16%
Cancer Cases
16%
Colorectal Cancer Patients
16%
Extramural Venous Invasion
16%
Improved Survival
16%
Postoperative Mobilization
12%
Ketone Monitoring
12%
Subcutaneous Insulin
12%
Platelet Ratio
10%
Cox Proportional Hazards Regression Model
8%
Neoadjuvant Therapy
8%
Patient Characteristics
8%
Dukes Stage
8%
Pathological Outcomes
8%
Improved Outcomes
8%
Overall Survival
8%
Invasion Status
8%
Symptomatic Patients
8%
All-cause Mortality
8%
Screening Population
8%
Symptomatic Cancer
8%
Multivariable
8%
Pathology Database
8%
Lymph Node Ratio
8%
Pathological Factors
8%
Young Population
8%
Pharmacology, Toxicology and Pharmaceutical Science
Injury
100%
Sodium Glucose Cotransporter 2 Inhibitor
50%
Diabetic Ketoacidosis
50%
Bleeding
50%
Randomized Controlled Trial
33%
Prospective Cohort Study
16%
Multiple Organ Failure
16%
Sepsis
16%
Thromboembolism
16%
Femur Fracture
12%
Non Insulin Dependent Diabetes Mellitus
12%
Adverse Event
12%
